 |
Innovatis AG develops, produces and distributes fully automated cell analysis equipment (bioprocess analysis). The systems overcome the drawbacks of manual analysis such as the high amounts of time and work involved, the restricted data that is acquired and the high margin of error. Innovatis AG's core competence is the interdisciplinary combination of biotechnological knowledge and digital image and pattern recognition in cell culture analysis. Its reference customers include almost all of the major pharmaceuticals companies and biotechnology companies such as Aventis, Bayer, Pfizer, Roche, Amgen and Genentech.
Ventizz Capital Funds sold innovatis AG to Roche Diagnostics in the mid of March 2009.
|
|
